Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress
Life Science Alliance · 2025
DOI: 10.26508/lsa.202302259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Milad Soleimani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Life Sciences Graduate Programs, The University of Texas at Austin, Austin, TX, USA. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Neoplastic Stem Cells, Triple Negative Breast Neoplasms, Stress, Physiological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CPRIT, UT College of Pharmacy Discretionary Funds, UT Graduate Continuing Fellowship.
Abstract (Originalsprache)
Breast cancer stem cells (CSCs) are difficult to therapeutically target, but continued efforts are critical given their contribution to tumor heterogeneity and treatment resistance in triple-negative breast cancer. CSC properties are influenced by metabolic stress, but specific mechanisms are lacking for effective drug intervention. Our previous work on TFEB suggested a key function in CSC metabolism. Indeed, TFEB knockdown (KD) inhibited mammosphere formation in vitro and tumor initiation/growth in vivo. These phenotypic effects were accompanied by a decline in CD44 high /CD24 low cells. Glycolysis inhibitor 2-deoxy-D-glucose (2-DG) induced TFEB nuclear translocation, indicative of TFEB transcriptional activity. TFEB KD blunted, whereas TFEB (S142A) augmented 2-DG–driven unfolded protein response (UPR) mediators, notably BiP/HSPA5 and CHOP. Like TFEB KD, silencing BiP/HSPA5 inhibited CSC self-renewal, suggesting that TFEB augments UPR-related survival. Further studies showed that TFEB KD attenuated 2-DG–directed autophagy, suggesting a mechanism whereby TFEB protects CSCs against 2-DG–induced stress. Our data indicate that TFEB modulates CSC metabolic stress response via autophagy and UPR. These findings reveal the novel role of TFEB in regulating CSCs during metabolic stress in triple-negative breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Life Sciences Graduate Programs, The University of Texas at Austin, Austin, TX, USA.
- Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
- Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.
- Interdisciplinary Life Sciences Graduate Programs, The University of Texas at Austin, Austin, TX, USA carla.vandenberg@austin.utexas.edu.
- Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.
ORCID-Profile: Ria Goyal, Jeanne Kowalski, Carla Van Den Berg
Förderung
- CPRIT
- UT College of Pharmacy Discretionary Funds
- UT Graduate Continuing Fellowship
Zitieren
APA
Soleimani, M., Duchow, M., Goyal, R., Somma, A., Kaoud, T. S., Dalby, K. N., Kowalski, J., Eckhardt, S. G., & Van Den Berg, C. (2025). Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress. Life Science Alliance. https://doi.org/10.26508/lsa.202302259
Vancouver
Soleimani M, Duchow M, Goyal R, Somma A, Kaoud TS, Dalby KN, et al. Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress. Life Science Alliance. 2025. doi:10.26508/lsa.202302259
BibTeX
@article{Soleimani2025,
author = {Soleimani, Milad and Duchow, Mark and Goyal, Ria and Somma, Alexander and Kaoud, Tamer S and Dalby, Kevin N and Kowalski, Jeanne and Eckhardt, S Gail and Van Den Berg, Carla},
title = {Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202302259}
}
EUVIMED